SHENZHEN EFUNG INVESTMENT MANAGEMENT

Efung Capital is one of the earliest private equity investment institutions developing venture capital businesses specializing in healthcare industry investment. Efung is composed of a high-caliber management team and an experienced investment team consisting of MDs/PhDs who graduated from top universities all over the world. For years, Efung Capital has been consistently pursuing the long-term value of biopharmaceuticals and high-end medical devices, including over 80 investment companies globally, such as Chipscreen Bioscience, Frontier Biotech, Ascentage Pharma, Lifotronic Technology, OBiO Technology , ASIERIS MediTech, 3D Medicines and Harbour BioMed et al... Shenzhen Efung Investment Management Co. Ltd.,(abbreviated as "Efung" or "Efung Capital") is one of Shenzhen's earliest professional venture capital firms and has been rated as"The Top Ten Venture Capital Institutions in Shenzhen" for many years. Over the years, Efung Capital has focused on healthcare industries-especially VC..

Also known as: Efung Capital, Shenzhen Efung Investment Management Co. Ltd.